Other Events ·
Apollomics Inc. regained compliance with the Nasdaq Capital Market's Market Value of Listed Securities (MVLS)…
APLMWApollomics Inc.
Apollomics Inc. regained compliance with the Nasdaq Capital Market's Market Value of Listed Securities (MVLS) requirement after maintaining a market value of $35 million or greater for 10 consecutive business days from June 23, 2026, to July 7, 2026. The company was previously non-compliant due to failure to meet the minimum $35 million threshold over a 30-day period. Apollomics Inc. is a biotechnology company focused on developing oncology treatments.